Scenic Biotech: one of Nature Biotechnology Academic Spinouts of 2017

We congratulate Scenic Biotech on being one of Nature Biotechnology Academic Spinouts of 2017. Nature Biotechnology: "... we believe these companies represent some of the best (and most richly financed) science that was commercialized from academia in 2017". Please...

Synaffix Launches toxSYN™, a New Platform of ADC Payloads

AMSTERDAM, NETHERLANDS – December 6, 2017 – Synaffix BV, a biotechnology company that has developed a proprietary site-specific conjugation platform technology to enable differentiated antibody-drug conjugates (ADCs), today announced the launch of a new platform of...